KDM5B has been shown to be overexpressed in several cancers, such as breast, prostate, and lung cancer, and is required for mammary tumor formation in xenograft mouse models (Catchpole et al., 2011; Yamane et al., 2007). Here, KDM5B is linked to lung cancer.